Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ¥27.29B | ¥29.23B | ¥31.87B | ¥29.00B | ¥30.55B | ¥29.71B | ¥28.99B | ¥24.99B | ¥17.38B | ¥11.24B |
| Research & development | ¥1.66B | ¥1.78B | ¥1.77B | ¥1.90B | ¥2.79B | ¥2.68B | ¥2.67B | ¥1.99B | ¥1.27B | ¥824.5M |
| Operating income | ¥229.3M | ¥1.81B | ¥2.99B | ¥1.31B | −¥4.48B | −¥6.04B | −¥9.26B | −¥8.31B | −¥3.95B | −¥2.79B |
| EBITDAderived | — | — | — | — | — | — | −¥8.30B | −¥7.65B | −¥3.49B | −¥2.38B |
| Net income | −¥206.3M | ¥764.1M | ¥1.93B | −¥136.2M | −¥6.17B | −¥7.04B | −¥10.32B | −¥9.11B | −¥3.74B | −¥3.07B |
| Basic EPSper diluted share | — | — | — | — | — | — | — | — | CN¥0.30 | -CN¥23.20 |
| Diluted EPSper diluted share | — | — | — | — | — | — | — | — | -CN¥1.15 | -CN¥23.20 |